The Current Ratio of Coherus Oncology Inc (CHRS) is
1.47.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
1.47
|
| 2024-12-31 |
1.21
|
| 2023-12-31 |
1.43
|
| 2022-12-31 |
2.75
|
| 2021-12-31 |
3.64
|
| 2020-12-31 |
5.27
|
| 2019-12-31 |
2.98
|
| 2018-12-31 |
2.53
|
| 2017-12-31 |
5.12
|
| 2016-12-31 |
2.86
|
| Ticker |
Name |
Value |
|
ADMS
|
Adamas Pharmaceuticals Inc
|
3.20
|
|
ATNX
|
Athenex Inc
|
1.09
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
1.54
|
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
4.88
|
|
STRO
|
Sutro Biopharma Inc
|
2.01
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
13.42
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
MDXG
|
MiMedx Group, Inc.
|
4.32
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
AMRN
|
Amarin Corporation PLC
|
3.34
|
|
CPRX
|
Catalyst Pharmaceuticals, Inc.
|
6.08
|
|
EGRX
|
Eagle Pharmaceuticals Inc
|
1.70
|
|
FLXN
|
Flexion Therapeutics Inc
|
4.08
|
|
HRBR
|
Harbor Diversified Inc
|
9.11
|
|
ORGO
|
Organogenesis Holdings Inc.
|
3.62
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
ENTA
|
Enanta Pharmaceuticals Inc
|
4.21
|
|
HRTX
|
Heron Therapeutics Inc
|
2.48
|
|
ICPT
|
Intercept Pharmaceuticals Inc
|
2.35
|
|
MGNX
|
MacroGenics Inc
|
5.10
|
|
MYGN
|
Myriad Genetics, Inc.
|
2.49
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
CDMO
|
Avid Bioservices Inc
|
1.47
|
|
ANIK
|
Anika Therapeutics Inc
|
4.72
|
|
CRIS
|
Curis Inc
|
0.49
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
TH.TO
|
Theratechnologies Inc
|
1.19
|
|
AKBA
|
Akebia Therapeutics Inc
|
1.55
|
|
TVTX
|
Travere Therapeutics, Inc.
|
2.74
|
|
MNKD
|
MannKind Corporation
|
1.70
|
|
PGEN
|
Precigen, Inc.
|
3.09
|
|
SVA
|
Sinovac Biotech Ltd
|
10.31
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
10.49
|